Subchronic dispositional and toxicological effects of arsenate administered in drinking water to mice

Journal of Toxicology and Environmental Health

Volumn 49, Issue 2, 1996, Pages 177-196

  Hughes, Michael F ^a   Thompson, Daniel J ^a  

^a ALION SCIENCE AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC ACID; CREATININE; DRINKING WATER; GLUCOSE; THIOL DERIVATIVE; TRIACYLGLYCEROL;

ANIMAL MODEL; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; FEMALE; HISTOLOGY; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; URINE VOLUME; WATER POLLUTION;

ADMINISTRATION, ORAL; ANIMALS; ARSENATES; BLOOD GLUCOSE; CHEMISTRY, CLINICAL; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; DRINKING BEHAVIOR; EATING; FECES; FEMALE; KIDNEY; LIVER; LUNG; MICE; ORGAN SIZE; SULFHYDRYL COMPOUNDS; TRIGLYCERIDES; URINE;

ANIMALIA;

EID: 0029903505     PISSN: 00984108     EISSN: None     Source Type: Journal    
DOI: 10.1080/00984108.1996.10662177     Document Type: Article

References (86)

1. Anundi, I., Hogberg, J., and Vahter, M. 1982. CSH release in bile as influenced by arsenite. FEBS Lett. 145:285-289.
2. Aposhian, H. V., and Aposhian, M. M. 1989. Newer developments in arsenic toxicity. J. Am. Coll. Toxicol. 8:1297-1305.
3. Axelson, O., Dahlgren, E., Jansson, C.-D., and Rehnlund, S. O. 1978. Arsenic exposure and mortality: A case-referent study from a Swedish copper smelter. Br. J. Ind. Med. 35:8-15.
4. Bates, M. N., Smith, A. H., and Cantor, K. P. 1995. Case-control study of bladder cancer and arsenic in drinking water. Am. J. Epidemiol. 141:523-530.
5. Beck, B. D., Boardman, P. D., Hook, C. C., Rudel, R. A., Slayton, T. M., and Carlson-Lynch, H. 1995. Response to Smith et al. (Letter). Environ. Health Perspect. 103:15-17.
6. Bencko, V., and Symon, K. 1969. Dynamics of arsenic cumulation in hairless mice after peroral administration. J. Hyg. Epidemiol. Microbiol. Immunol. 13:248-253.
7. Bencko, V., and Symon, K. 1970. The cumulation dynamics in some tissue of hairless mice inhaling arsenic. Atmos. Environ. 4:157-161.
8. 74As) in mice preliminarily exposed to the element in drinking water: A study in arsenic tolerance.J. Hyg. Epidemiol. Microbiol. Immunol. 17:165-168.
9. 74As labeled arsenite. Toxicology 20:35-44.
10. Borum, D. R., and Abernathy, C. O. 1994. Human oral exposure to inorganic arsenic. In Arsenic. Exposure and health, eds. W. R. Chappell, C. O. Abernathy, and C. R. Cothern, pp. 21-29. Northwood, United Kingdom: Science and Technology Letters.
11. Braman, R. S., and Forebeck, L. L. 1973. Methylated forms of arsenic in the environment. Science 182:1247-1249.
12. Brown, M. M., Rhyne, B. C., Coyer, R. A., and Fowler, B. A. 1976. Intracellular effects of chronic arsenic administration on renal proximal tubule cells. J. Toxicol. Environ. Health 1:505-514.
13. Buchet, J. P., and Lauwerys, R. 1987. Study of factors influencing the in vivo methylation of inorganic arsenic in rats. Toxicol. Appl. Pharmacol. 91:65-74.
14. Buchet, J. P., and Lauwerys, R. 1988. Role of thiols in the in vitro methylation of inorganic arsenic by rat liver cytosol. Biochem. Pharmacol. 37:3149-3153.
15. Carlson-Lynch, H., Beck, B. D., and Boardman, P. D. 1994. Arsenic risk assessment. Environ. Health Perspect. 102:354-356.
16. Challenger, F. 1945. Biological methylation. Chem. Rev. 36:315-361.
17. 74As]-arsenic acid in the hamster. Toxicol. Lett. 5:175-182.
18. Chilvers, D. C., and Peterson, P. J. 1987. Global cycling of arsenic. In Lead, mercury, cadmium and arsenic in the environment, eds. T. C. Hutchinson and K. M. Meema, pp. 279-301. New York: John Wiley and Sons.
19. Chiou, H.-Y., Hsueh, Y.-M., Liaw, K.-F., Horng, S.-F., Chiang, M.-H., Pu, Y.-S., Lin, J.-S.-N., Huang, C.-H., and Chen, C.-J. 1995. Incidence of internal cancers and ingested inorganic arsenic: A seven-year follow-up study in Taiwan. Cancer Res. 55:1296-1300.
20. u on glucose tolerance in Wistar rats. Nutr. Res. 15:555-564.
21. Cullen, W. R., McBride, B. C., and Reglinski, J. 1984. The reaction of methylarsenicals with thiols: Some biological implications. J. Inorg. Biochem. 21:179-181.
22. Dabeka, R. W., McKenzie, A. D., Lacroix, M. A., Cleroux, C., Bowe, S., Graham, R. A., Bonacher, H. B. S., and Verdier, P. 1993. Survey of arsenic in total diet food composites and estimation of the dietary intake of arsenic by Canadian adults and children. J. Assoc. Off. Anal. Chem. 76:14-25.
23. Davis, M. E., and Berndt, W. O. 1994. Renal methods for toxicology. In Principles and methods of toxicology, 3rd ed., ed. A. W. Hayes, pp. 871-894. New York: Raven Press.
24. Delnomdedieu, M., Basti, M. M., Otvos, J. D., and Thomas, D. J. 1993. Transfer of arsenite from glutathione to dithiols: A model of interaction. Chem. Res. Toxicol. 6:598-602.
25. Delnomdedieu, M., Basti, M. M., Styblo, M., Otvos, J. D., and Thomas, D. J. 1994. Complexation of arsenic species in rabbit erythrocytes. Chem. Res. Toxicol. 7:621-627.
26. Engel, R. R., and Smith, A. H. 1994. Arsenic in drinking water and mortality from vascular disease: An ecological analysis in 30 counties in the United States. Arch. Environ. Health 49:418-427.
27. Fowle, J. R., Abernathy, C. O., Mass, M. J., McKinney, J. D., North, D. W., Ohanian, E. V., and Uthus, E. 1992. Arsenic health research needs. Trace Subst. Environ. Health 25:1-14.
28. Gaines, T. B., and Linder, R. E. 1986. Acute toxicity of pesticides in adult and weanling rats. Fundam. Appl. Toxicol. 7:299-308.
29. Gregus, Z., and Klaassen, C. D. 1986. Disposition of metals in rats: A comparative study of fecal, urinary, and biliary excretion and tissue distribution of eighteen metals. Toxicol. Appl. Pharmacol. 85:24-38.
30. Gyurasics, A., Varga, F., and Gregus, Z. 1991a. Effect of arsenicals on biliary excretion of endogenous glutathione and xenobiotics with glutathione-dependent hepatobiliary transport. Biochem. Pharmacol. 41:937-944.
31. Gyurasics, A., Varga, F., and Gregus, Z. 1991b. Glutathione-dependent biliary excretion of arsenic. Biochem. Pharmacol. 42:465-468.
32. Hindmarsh, J. T., and McCurdy, R. F. 1986. Clinical and environmental aspects of arsenic toxicity. CRCCrit. Rev. Clin. Lab. Sci. 23:315-347.
33. Hirata, M., Hisanaga, A., Tanaka, A., and Ishinishi, N. 1988. Glutathione and methylation of inorganic arsenic in hamsters. Appl. Organomet. Chem. 2:315-321.
34. Hirata, M., Mohri, T., Hisanaga, A., and Ishinishi, N. 1989. Conversion of arsenite and arsenate to methylarsenic and dimethylarsenic compounds by homogenates prepared from livers and kidneys of rats and mice. Appl. Organomet. Chem. 3:335-341.
35. Hirata, M., Tanaka, A., Hisanaga, A., and Ishinishi, N. 1990. Effects of glutathione depletion on the acute nephrotoxic potential of arsenite and on arsenic metabolism in hamsters. Toxicol. Appl. Pharmacol. 106:469-481.
36. Hopenhayn-Rich, C., Smith, A. H., and Goeden, H. M. 1993. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ. Res. 60:161-177.
37. Hughes, M. F., Menache, M., and Thompson, D. J. 1994. Dose-dependent disposition of sodium arsenate in mice following acute oral exposure. Fundam. Appl. Toxicol. 22:80-89.
38. IARC. 1980. Some metals and metallic compounds. Monogr. Eval. Carcinogen. Risk Chem. Man 23:39-141. Lyon, France: IARC.
39. IARC. 1987. Arsenic and arsenic compounds (Group 1). IARC Monogr. Eval. Carcinogen. Risk Hum. Suppl. 7:100-106. Lyon, France: IARC.
40. Ishinishi, N., Tscuhiya, K., Vahter, M., and Fowler, B. A. 1986. Arsenic. In Handbook on the toxicology of metals, 2nd ed., eds. L. Friberg, G. F. Nordberg, and V. Vouk, pp. 43-83. Amsterdam: Elsevier.
41. Jolliffe, D. M. 1993. A history of the use of arsenicals in man. J. R. Soc. Med. 86:287-289.
42. Klaassen, C. D. 1974. Biliary excretion of arsenic in rats, rabbits and dogs. Toxicol. Appl. Pharmacol. 29:447-457.
43. Lerman, S., and Clarkson, T. W. 1983. The metabolism of arsenite and arsenate by the rat. Fundam. Appl. Toxicol. 3:309-314.
44. Luchtrath, H. 1983. The consequences of chronic arsenic poisoning among Moselle wine growers. J. Cancer Res. Clin. Oncol. 105:173-182.
45. Marafante, E., Vahter, M., Norin, H., Envall, J., Sandstrom, M., Christakopoulos, A., and Ryhage, R. 1987. Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol. 7:111-117.
46. Marcus, W. L., and Rispin, A. S. 1988. Threshold carcinogenicity using arsenic as an example. In Advances in modern environmental toxicology: Risk assessment and risk management of industrial and environmental chemicals, eds. C. R. Cothern and M. A. Mehlman, pp. 133-158. Princeton, NJ.: Princeton Publishing.
47. Murai, T., Iwata, H., Otoshi, T., Endo, G., Horiguchi, S., and Fukushima, S. 1993. Renal lesions induced in F344/DuCrj rats by 4-weeks oral administration of dimethylarsinic acid. Toxicol. Lett. 66:53-61.
48. National Academy of Sciences. 1977. Medical and Biological Effects of Environmental Pollutants: Arsenic. Washington, DC: NAS.
49. Naqvi, S. M., Vaishnavi, C., and Singh, H. 1994. Toxicity and metabolism of arsenic in vertebrates. In Arsenic in the environment. Part II: Human health and ecosystems effects, ed. J. O. Nriagu, pp. 55-91. New York: John Wiley & Sons.
50. Odanaka, Y., Matano, O., and Goto, S. 1980. Biomethylation of inorganic arsenic by the rat and some laboratory animals. Bull. Environ. Contam. Toxicol. 24:452-459.
51. Peters, R. A. 1955. Biochemistry of some toxic agents. I. Present state of knowledge of biochemical lesions induced by trivalent arsenical poisoning. Bull. John Hopkins Hosp. 97:1-20.
52. Petito, C. T., and Beck, B. D. 1990. Evaluation of evidence of nonlinearities in the dose-response curve for arsenic carcinogenesis. Trace Subst. Environ. Health 24:148-176.
53. Plaa, G. L., and Charbonneau, M. 1994. Detection and evaluation of chemically induced liver injury. In Principles and methods of toxicology, 3rd ed., ed. A. W. Hayes, pp. 839-870. New York: Raven Press.
54. 74As-labeled arsenate and arsenite for use in biological experiments. Anal. Biochem. 78:557-560.
55. Sanders, J. G. 1980. Arsenic cycling in marine systems. Mar. Environ. Res. 3:257-266.
56. Scott, N., Hatlelid, K. M., Mackenzie, N. E., and Carter, D. E. 1993. Reactions of arsenic(lll) and arsenic(V) species with glutathione. Chem. Res. Toxicol. 6:102-106.
57. Sedlak, J., and Lindsay, R. H. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 24:192-205.
58. Smith, A. H., Hopenhayn-Rich, C., Bates, M. N., Goeden, H. M., Hertz-Picciotto, I., Duggan, H. M., Wood, R., Kosnett, M. J., and Smyth, M. T. 1992. Cancer risks from arsenic in drinking water. Environ. Health Perspect. 97:259-267.
59. Smith, A. H., Biggs, M. L., Hopenhayn-Rich, C., and Kalman, D. 1995. Arsenic risk assessment (letter). Environ. Health Perspect. 103:13-15.
60. 74As-cacodylic acid in rats after intravenous, intratracheal, or peroral administration. Environ. Health Perspect. 19:151-157.
61. Stohrer, C. 1991. Arsenic: Opportunity for risk assessment. Arch. Toxicol. 65:525-531.
62. Styblo, M., Hughes, M. F., and Thomas, D. J. 1996. Liberation and analysis of protein-bound arsenicals.J. Chrom. B 677:161-166.
63. Sweet, D. V., ed. 1987. Registry of Toxic Effects of Chemical Substances, 1985-1986 Edition, Vol. 1. Washington, DC: U.S. Department of Health and Human Services, Public Health Service.
64. 2Oj on gluconeogenesis. Arch. Toxicol. 61:444-449.
65. Takahashi, K., Yamauchi, H., Mashiko, M., Yamamura, Y. 1990. Effect of 5-adenosyl-methionine on methylation of inorganic arsenic. Nippon Eiseigaku Zasshi 45:613-618.
66. 74As. Anal. Biochem. 86:505-511.
67. 74As) in humans following oral ingestion. Toxicol. Appl. Pharmacol. 50:319-322.
68. Thompson, D. J. 1993. A chemical hypothesis for arsenic methylation in mammals. Chem. Biol. Interact. 88:89-114.
69. Tseng, W.-P. 1977. Effects of dose-response relationship of skin cancer and Blackfoot disease with arsenic. Environ. Health Perspect. 19:109-119.
70. Tseng, W.-P., Chu, H. M., How, S. W., Fong, J. M., Lin, C. S., and Yeh, S. 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40:453-563.
71. Tsuda, T., Babazono, A., Yamamoto, E., Kurumatani, N., Mino, Y., Ogawa, T., Kishi, Y., and Aoyama, H. 1995. Ingested arsenic and internal cancer: A historical cohort study followed for 33 years. Am. J. Epidemiol. 141:198-209.
72. Uhlig, S., and Wendel, A. 1992. The physiological consequences of glutathione variations. Life Sci. 51:1083-1094.
73. U.S. Environmental Protection Agency. 1984. Health Assessment Document of Inorganic Arsenic. EPA/600/8-83/021F. Washington, DC: Office of Health and Environmental Assessment, U.S. Environmental Protection Agency.
74. U.S. Environmental Protection Agency. 1988. Special Report on Ingested Inorganic Arsenic. Skin Cancer; Nutritional Essentiality. EPA/625/3-87/013. Washington, DC: Risk Assessment Forum, U.S. Environmental Protection Agency.
75. U.S. Food and Drug Administration. 1992. Printout of FDA Market Basket Studies, 1982-1990. U.S. FDA, Washington, DC.
76. Vahter, M. 1981. Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environ. Res. 25:286-293.
77. Vahter, M., and Envall, J. 1983. In vivo reduction of arsenate in mice and rabbits. Environ. Res. 32:14-24.
78. Vahter, M., and Marafante, E. 1985. Reduction and binding of arsenate in marmoset monkeys. Arch. Toxicol. 57:119-124.
79. Vahter, M., and Marafante, E. 1988. In vivo methylation and detoxication of arsenic. In Biological alkylation of heavy elements, eds. P. j. Craig and F. Glockling, pp. 105-119. London, UK: Royal Society of Chemistry.
80. 74As-labeled trivalent and pentavalent inorganic arsenic in mice. Environ. Res. 21:446-457.
81. 74As-arsenite. Arch. Toxicol. 51:65-77.
82. 74As-dimethylarsinic acid in mice and rats. Arch. Environ. Contam. Toxicol. 13:259-264.
83. Vahter, M., Couch, R., Neuwell, B., and Nilsson, R. 1995. Lack of methylation of inorganic arsenic in the chimpanzee. Toxicol. Appl. Pharmacol. 133:262-268.
84. Yamamoto, S., Konishi, Y., Matsuda, T., Murai, T., Shibata, M.-A., Matsui-Yuasa, I., Otani, S., Kuroda, K., Endo, G., and Fukushima, S. 1995. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid) in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55:1271-1276.
85. Yamanaka, K., Hasegawa, A., Sawamura, R., and Okada, S. 1991. Cellular response of oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice. Toxicol. Appl. Pharmacol. 108:205-213.
86. Yamauchi, H., and Yamamura, Y. 1984. Metabolism and excretion of orally administered dimethylarsinic acid in the hamster. Toxicol. Appl. Pharmacol. 74:134-140.